NCT06227975View on ClinicalTrials.gov

A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-BMS-986368 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-BMS-986368

Specified dose on specified days

Trial Locations (1)

53704-2526

Local Institution - 0001, Madison

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY